Extensive gastrectomy and carbon-adsorbed mitomycin C for gastric cancer with peritoneal metastases. Case reports of survivors and their implications

Hepato-Gastroenterology

Volumn 46, Issue 27, 1999, Pages 1673-1677

  Hagiwara, Akeo ^a   Togawa, Takeshi ^a   Yamasaki, Junya ^a   Ohgaki, Masaharu ^a   Imanishi, Tsutomu ^a   Shirasu, Morio ^a   Sakakura, Chouhei ^a   Yamaguchi, Toshiharu ^a   Sawai, Kiyoshi ^a   Yamagishi, Hisakazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

5 Year survivors; Activated carbon; Gastric cancer; Mitomycin C; Peritoneal metastases

Indexed keywords

ACTIVATED CARBON; MITOMYCIN C;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; OMENTUM; PERITONEUM METASTASIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH CANCER;

ADENOCARCINOMA; ADSORPTION; ADULT; AGED; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CHARCOAL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DOSAGE FORMS; FEMALE; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; MITOMYCIN; OMENTUM; PERITONEAL NEOPLASMS; RABBITS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 0032804744     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Maehara Y, Moriguchi S, Kakeji Y, et al: Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis. Surgery 1991; 110:820-823.
2. Hagiwara A, Sakakura C, Shirasu M, et al: Complete omentectomy and extensive lymphadenectomy with gastrectomy improves the survival of gastric cancer patients with metastases in the adjacent peritoneum. Hepato-Gastroenterol 1998; 45:1922-1929.
3. Hagiwara A, Takahashi T, Ueda T, Lee R, Takeda M, Itoh T: Intraoperative chemotherapy with carbon particles adsorbing mitomycin C for gastric cancer with peritoneal dissemination in rabbits. Surgery 1988; 104:871-881.
4. Japanese Classification of Gastric Carcinoma: Japanese Research Society for Gastric Cancer. 1st Edition. Tokyo: Kanehara & Co., Ltd. Tokyo 1995.
5. Yonemura Y, Sawa T, Kinoshita K, et al: Neoadjuvant chemotherapy for high-grade advanced gastric cancer. World J Surg 1993; 17:256-262.
6. Rusznyak I, Foldi M, Szabo G: Filtration and absorption through serous membranes. In: Youlten L (Ed.). Lymphatics and Lymph Circulation. 2nd Edition. Oxford: Pergamon Press 1967; pp. 475-510.
7. Hagiwara A, Takahashi T, Lee R, Ueda T, Takeda M, Itoh T: Selective delivery of high levels of mitomycin C to peritoneal carcinomatosis using a new dosage form. Anticancer Res 1986; 6:1161-1164.
8. Hagiwara A, Takahashi T, Lee R, Ueda T, Takeda M, Itoh T: Enhanced chemotherapeutic efficacy on carcinomatous peritonitis using a new dosage form in animal experiments. Anticancer Res 1987; 7:167-170.
9. Hagiwara A, Takahashi T, Kojima O, et al: Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer. Lancet 1992; 339:629-631.
10. Takahashi T, Hagiwara A, Shimotsuma M, et al: Prophylaxis and treatment of peritoneal carcinomatosis: Intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles. World J Surg 1995; 19:565-569.